ProShares Ultra NASDAQ Biotechnology
41 hedge funds and large institutions have $34.8M invested in ProShares Ultra NASDAQ Biotechnology in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 8 closing their positions.
Holders
41
Holders Change
+3
Holders Change %
+7.89%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
11
Reduced
6
Closed
8
Calls
$13.2M
Puts
$13.9M
Net Calls
-$648K
Net Calls Change
+$12.7M